Toyobo Co., Ltd.

Overview

Toyobo Co., Ltd. is a Japanese corporation that actively invests in biotechnology startups, particularly in the United States, to foster open innovation and enhance productivity within the bio-business sector. The company has engaged in several strategic partnerships and investments to support the growth of innovative biotech companies. In January 2022, Toyobo invested in DMC Biotechnologies Inc., a U.S.-based biotech startup specializing in developing chemical products through precision microbe fermentation. This investment aims to leverage DMC's advanced fermentation technologies to improve the efficiency of Toyobo's bioproducts. Additionally, in June 2023, Toyobo joined the JMTC Healthcare Investment Limited Partnership, a fund established to accelerate startups engaged in healthcare-related businesses, further demonstrating its commitment to supporting the growth of healthcare-related startups. Toyobo's investment strategy focuses on fostering open innovation by collaborating with external organizations, including startups and academic institutions. The company seeks to create business collaboration opportunities with startups developing technologies compatible with its business fields, thereby contributing to the realization of a sustainable society through the promotion of biomanufacturing and other innovative solutions.

Investment Focus

• Innovative biotechnology solutions
• Alignment with Toyobo's business fields
• Potential for sustainable impact

Portfolio Companies